首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Mechanochemical Solid-State Polymerization (XI): Effect of Water-Insoluble Pharmaceutical Aids on Drug Release from Mechanically Synthesized Polymeric Prodrugs.
【24h】

Mechanochemical Solid-State Polymerization (XI): Effect of Water-Insoluble Pharmaceutical Aids on Drug Release from Mechanically Synthesized Polymeric Prodrugs.

机译:机械化学固态聚合(XI):水不溶性药物助剂对机械合成的聚合前药释放药物的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

We discuss here the effect of water-insoluble pharmaceutical aids on the nature of drug release from composite polymeric prodrugs synthesized by mechanochemical solid-state polymerization. Magnesium stearate (Mgst) and hydrogen castor oil (HCO) were used as water-insoluble pharmaceutical aids. Composite polymeric prodrugs were synthesized by the mechanochemical solid-state polymerization of a vinyl monomer of 5-fluorouracil (I) in the presence of Mgst or HCO. The molecular weight of the resulting polymeric prodrugs increased with increasing the content of Mgst or HCO. Prodrug hydrolysis was carried out in a heterogeneous system in phosphate buffer at pH 6.8 and 37 degrees C. The rate of drug release from the composite polymeric prodrug containing Mgst (Poly-Mgst) was faster than that from polymeric prodrug containing no pharmaceutical aids (Poly-Non), while hydrolysis of the composite polymeric prodrug containing HCO (Poly-HCO) was slower than Poly-Non. Scanning electron microscope (SEM) photos showed the surface of Poly-HCO was smoother than that of Poly-Non and Poly-Mgst. It was suggested that the slower drug release from Poly-HCO may be responsible for the smaller specific surface area than that of Poly-Non. It was also shown that the rate of drug release from the composite polymeric prodrugs decreases with increasing the content of Mgst or HCO. Hence, novel composite polymeric prodrugs with a variety of drug release rates can be prepared by mechanochemical solid-state polymerization in a totally dry process.
机译:我们在这里讨论水不溶性药物助剂对通过机械化学固态聚合合成的复合聚合物前药释放药物的性质的影响。硬脂酸镁(Mgst)和氢蓖麻油(HCO)用作水不溶性药物助剂。在Mgst或HCO存在下,通过5-氟尿嘧啶(I)乙烯基单体的机械化学固态聚合反应合成了复合聚合物前药。随着Mgst或HCO含量的增加,所得聚合物前药的分子量增加。前药水解是在pH 6.8和37摄氏度的磷酸盐缓冲液的非均相系统中进行的。药物从含Mgst的复合聚合物前药(Poly-Mgst)释放的速率快于不含药物助剂的聚合前体药物(Poly-Mgst)的释放速率。 -Non),而含HCO(Poly-HCO)的复合聚合物前药的水解比Poly-Non慢。扫描电子显微镜(SEM)照片显示,Poly-HCO的表面比Poly-Non和Poly-Mgst的表面光滑。有人提出,从聚-HCO中释放较慢的药物可能是比聚-Non较小的比表面积。还显示出,随着Mgst或HCO含量的增加,从复合聚合物前药中释放药物的速率降低。因此,可以通过机械化学固态聚合在完全干燥的过程中制备具有多种药物释放速率的新型复合聚合物前药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号